Q54X15 AF NFT

Type-2 histone deacetylase 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic54dgrddglbtb7z7ay7gvcr7zmparfxuoffnv3m3ksblosa5775y/metadata.json
IPFS of structure file: 
bafybeibxiidzvkojapigo64ivxttozfyvsngdihgen5insb4bt7ekjydyu/AF-Q54X15-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x431B390Bd1BB4D49138DB71A9E1d789A246f702e
First NFT owner address (bech32): 
genesis1gvdnjz73hdx5jyudkudfu8tcngjx7upwaha4kj
Current NFT ID #165886 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
165886
Accession (UniProt):
Q54X15
Name::
Type-2 histone deacetylase 1
Experimental Method:
Predicted structure
Sequence source:
DICTYOSTELIUM DISCOIDEUM

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q54X15 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q54X15|HDA21_DICDI Type-2 histone deacetylase 1 OS=Dictyostelium discoideum OX=44689 GN=hdaD PE=2 SV=1 MSTIHQVNEMNSRVGEKPACCIGAARGHCTAHCPRIEDVLYSQRKGKTNKGAQRWRCKACGTKWTSKGIIIQPPVVPDTIVNSIGFGNGPEEISMEQLRANARPYKKTKTGDNILQTSPFPSLFGNSIGMGLGGNNNNINNNNNSNGSNSSNNSHNGGSSPSGSPIPSPPSPVSFLQRNSNVFVPILPQSNGNNINNNNNNNSNSNSNNINSNSSNSMQLQNNNNNNGQLRSSSSSLSLSSSSSQLNSSSNGNGSSRNLLTSQKSAQSLIGNINNNNNNNNIINNNSNNNTNNNNNIMNGTTTSTTKPVVVGGPMQILNSVVNNSPTSSKPILSSSSQNLLYNSSGSIPQPSQSPQNNNNTTINNNNNTTNNNNNNNNSNNNNNSNNNNNNSNNNNINNVANGTPRPSLQTSRLQGKLPSPQQYNTSPSHQQYPSPKNNNNSNNIIPIQSTYGQPTPPPTKPPVSSKAPAVYHNVRVPSPNTTVDNNNNNNNNNNNNNNNNNNNNNNNNNNNSNNNNNSNNNNNNINNNNNNNNNSNNNNNGNSNNNNNNNSNYQQQHQYFSPNQNYIQQQVQAVQTQQAQHILAQQQAQAQQQYIQQLQLQQQTLAHAQSQAAHQAQTLTHSRHNDLLSPIDSQIWAPIQYSWIQTHYNPSSSLLECLKRLINSVVVFSNELPVDQRLKMINFLTTLSSPSSESQYNTNASKQMLNCIDNSVFNITKHYQMLYQSISKHYSMMEDSFIPLTEVYFDENEINKFIHFSDQFKIIEEQFEFILRELSSIRDTLIIKRENIEKNIIESSKFLNNSSNNDNGIEEIGLEQAKQDTTRLLESLAPLETTLNSMEIKFKSIQKEISMVIRVFSFFELLYNIHINCHQTIVEKHSRQLSTYMIDVIQQSLYNCDVISVAYNRLKTGLFNSNNNNNNNNNNNNNNNEEDDQLIDTTNPFINKLSDLLSKYENISKNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNRNRDRDREFERDNNSNNNNNNIEKERNRNNRIRDRDNMDIDNISSFISNNQQQHIGQSQSVQQSSQLPKERKVMALYHTTCLDHLVPDDHPESPKRLSSVIKAINDFSRQSDRLIIKNDPEEINDKWILTVHSPEYLRLLEDLTEKLDANEIRPLNVNNDGASTGINQFSTSTPITTTGTATVTPGSTTSSTNGEQCEDGDTFVSKLSLHAAKRSAGATCQAIDNVMKGNVTSAFVAARPPGHHAGRDGLTSGTSSQGFCLLNHVCIGAKYAQLKYNLDKIAIIDFDVHHGNGTEEILSNDQGFYFLSIHMFEEGFYPGSGGGVGSIGVVNLNEFNEQNDYDDDDNNNDVNNNNNNNNNNNNNNNNNNNNKNNNNNNSNSITQQSTITNNSNCKGNIVNIPLDPKSSASSFLKAFSIIIDKLNDYQPELILISCGFDAHMEDHLASLCLLEENYVEITRSLRRVADRWCKGRLVSILEGGYNINALRQCTIAHLSALSEDD